Despite recent advances in pharmacological therapy for managing patients with type 2 diabetes, most patients are still unable to reach glycemic targets. According to the National Health and Nutrition Examination Survey, data indicate that only half of people with diabetes are achieving an A1C <7%, and a plateau in glycemic control has been observed (1).
According to the American Diabetes Association (ADA), diabetes care should be managed by a multidisciplinary team, which may include pharmacists and other health care professionals (2). Pharmacists are well suited to support co-management of diabetes to provide patients with interventions such as education, monitoring responses, selection of therapy, and promotion of adherence to self-care and therapeutic regimens. The role of the pharmacist in diabetes care has begun to evolve in specialty clinics such as endocrinology, where the most complex patients with diabetes receive care (3,4). There is...
